Dark Blue Therapeutics
UKEntry
2020
Hold
6yr
Exit
2026
Who owns Dark Blue Therapeutics?
Dark Blue Therapeutics was owned by Oxford Science Enterprises through Oxford Science Enterprises Balance Sheet (2015 vintage) from 2020 to 2026, exited via Trade Sale.
Buyer identity available on Pro.
Hand-verified · updated 2026-06-11
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2026
More from Oxford Science Enterprises Balance Sheet
Other portfolio companies in the same fund.
More PE-backed in Biotech
Comparable biotech deals from other GPs.
FranceTrack Dark Blue Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Get the full record on Dark Blue Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue